| Dr Eric S Lieberman, MD | |
|
1 Diamond Hill Rd, Summit Medical Group, Berkeley Heights, NJ 07922-2104 | |
| (908) 273-4300 | |
| (908) 673-7241 |
| Full Name | Dr Eric S Lieberman |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 26 Years |
| Location | 1 Diamond Hill Rd, Berkeley Heights, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275522252 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 25MA07783200 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Summit Medical Group Pa | 5395642276 | 1253 |
News Archive
Forest Laboratories Holdings Limited, a wholly owned subsidiary of Forest Laboratories, Inc. today announced that the company is acquiring exclusive rights in the United States for Saphris (asenapine) sublingual tablets, a treatment for adult patients with schizophrenia or acute bipolar mania, from Merck Sharp & Dohme B.V., a wholly owned subsidiary of Merck & Co., Inc.
Cabozantinib, a drug already used to treat patients with certain types of thyroid or kidney cancer, was able to eradicate invasive prostate cancers in mice by causing tumor cells to secrete factors that entice neutrophils - the first-responders of the immune system - to infiltrate the tumor, where they triggered an immune response that led to tumor clearance.
Among its many talents, silver is an antibiotic. Titanium dioxide is known to glom on to certain heavy metals and pollutants. Yet other materials do the same for salt. In recent years, environmental engineers have sought to disinfect, depollute, and desalinate contaminated water using nanoscale particles of these active materials. Engineers call them nanoscavengers. The hitch from a technical standpoint is that it is nearly impossible to reclaim the nanoscavengers once in the water.
Adverse events, or side effects, have traditionally been viewed as an unavoidable consequence in the therapeutic treatment of cancer patients. Yet sufficient data exists to study the relationship between molecular mechanisms, and drug-induced phenotypes to learn about - and even predict - adverse events in patients.
› Verified 3 days ago
| Entity Name | Summit Medical Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942254347 PECOS PAC ID: 5395642276 Enrollment ID: O20031218000011 |
News Archive
Forest Laboratories Holdings Limited, a wholly owned subsidiary of Forest Laboratories, Inc. today announced that the company is acquiring exclusive rights in the United States for Saphris (asenapine) sublingual tablets, a treatment for adult patients with schizophrenia or acute bipolar mania, from Merck Sharp & Dohme B.V., a wholly owned subsidiary of Merck & Co., Inc.
Cabozantinib, a drug already used to treat patients with certain types of thyroid or kidney cancer, was able to eradicate invasive prostate cancers in mice by causing tumor cells to secrete factors that entice neutrophils - the first-responders of the immune system - to infiltrate the tumor, where they triggered an immune response that led to tumor clearance.
Among its many talents, silver is an antibiotic. Titanium dioxide is known to glom on to certain heavy metals and pollutants. Yet other materials do the same for salt. In recent years, environmental engineers have sought to disinfect, depollute, and desalinate contaminated water using nanoscale particles of these active materials. Engineers call them nanoscavengers. The hitch from a technical standpoint is that it is nearly impossible to reclaim the nanoscavengers once in the water.
Adverse events, or side effects, have traditionally been viewed as an unavoidable consequence in the therapeutic treatment of cancer patients. Yet sufficient data exists to study the relationship between molecular mechanisms, and drug-induced phenotypes to learn about - and even predict - adverse events in patients.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eric S Lieberman, MD 1 Diamond Hill Rd, Summit Medical Group, Berkeley Heights, NJ 07922-2104 Ph: (908) 273-4300 | Dr Eric S Lieberman, MD 1 Diamond Hill Rd, Summit Medical Group, Berkeley Heights, NJ 07922-2104 Ph: (908) 273-4300 |
News Archive
Forest Laboratories Holdings Limited, a wholly owned subsidiary of Forest Laboratories, Inc. today announced that the company is acquiring exclusive rights in the United States for Saphris (asenapine) sublingual tablets, a treatment for adult patients with schizophrenia or acute bipolar mania, from Merck Sharp & Dohme B.V., a wholly owned subsidiary of Merck & Co., Inc.
Cabozantinib, a drug already used to treat patients with certain types of thyroid or kidney cancer, was able to eradicate invasive prostate cancers in mice by causing tumor cells to secrete factors that entice neutrophils - the first-responders of the immune system - to infiltrate the tumor, where they triggered an immune response that led to tumor clearance.
Among its many talents, silver is an antibiotic. Titanium dioxide is known to glom on to certain heavy metals and pollutants. Yet other materials do the same for salt. In recent years, environmental engineers have sought to disinfect, depollute, and desalinate contaminated water using nanoscale particles of these active materials. Engineers call them nanoscavengers. The hitch from a technical standpoint is that it is nearly impossible to reclaim the nanoscavengers once in the water.
Adverse events, or side effects, have traditionally been viewed as an unavoidable consequence in the therapeutic treatment of cancer patients. Yet sufficient data exists to study the relationship between molecular mechanisms, and drug-induced phenotypes to learn about - and even predict - adverse events in patients.
› Verified 3 days ago
Silpa Gadiraju, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922 Phone: 908-273-4300 Fax: 908-673-7336 | |
Dr. John H Dokko, DO Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Summit Medical Group, Berkeley Heights, NJ 07922 Phone: 908-273-4300 Fax: 908-277-8808 | |
Dr. Lawrence J Nastro, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 1 Diamond Hill Rd, Summit Medical Group, Berkeley Heights, NJ 07922 Phone: 908-273-4300 Fax: 908-277-8825 | |
Christopher M Boni, DO Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922 Phone: 908-277-8683 Fax: 908-608-2378 | |
Dr. Jeffrey Okun, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922 Phone: 908-273-4300 | |
Dr. Michele Elkins, M.D Rheumatology Medicare: Medicare Enrolled Practice Location: 1060 Mountain Ave, Berkeley Heights, NJ 07922 Phone: 908-464-6740 | |
Shruti P Dhorajia, D.O. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922 Phone: 908-273-4300 |